What question did this study set out to answer?

The study aims to evaluate the effectiveness of an oral bedaquiline regimen for treating multidrug-resistant tuberculosis (TB) in China.

April 4, 2026Infection2 citationsOpen Access

Evaluation of an oral bedaquiline regimen for treating multidrug-resistant TB in China: a randomized trial

The study aims to evaluate the effectiveness of an oral bedaquiline regimen for treating multidrug-resistant tuberculosis (TB) in China.
Randomized trial design
Investigated an oral regimen of bedaquiline
Focused on multidrug-resistant TB cases
Conducted in multiple clinical settings
Oral bedaquiline demonstrated improved treatment outcomes
Participants exhibited higher recovery rates
Reduced side effects compared to traditional therapies

gov NCT05306223. Prospectively registered on 16 March 2022.

AI에게 질문

Bookmark

View Full Paper

AI에게 질문

Bookmark

View Full Paper